Gaëtan Billioud

431 total citations
8 papers, 356 citations indexed

About

Gaëtan Billioud is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Gaëtan Billioud has authored 8 papers receiving a total of 356 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Epidemiology, 6 papers in Hepatology and 5 papers in Infectious Diseases. Recurrent topics in Gaëtan Billioud's work include Hepatitis B Virus Studies (7 papers), Hepatitis C virus research (6 papers) and Liver Disease Diagnosis and Treatment (3 papers). Gaëtan Billioud is often cited by papers focused on Hepatitis B Virus Studies (7 papers), Hepatitis C virus research (6 papers) and Liver Disease Diagnosis and Treatment (3 papers). Gaëtan Billioud collaborates with scholars based in France, United States and Austria. Gaëtan Billioud's co-authors include Fabien Zoulim, Christian Pichoud, Stéphanie Villet, S. Durantel, Christian Trépo, Luc Barraud, Gerhard Puerstinger, Johan Neyts, Camille Sureau and Julie Lucifora and has published in prestigious journals such as Gastroenterology, Journal of Hepatology and Antiviral Research.

In The Last Decade

Gaëtan Billioud

8 papers receiving 350 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gaëtan Billioud France	7	323	297	104	30	18	8	356
Ros Edwards Australia	6	457 1.4×	423 1.4×	147 1.4×	49 1.6×	59 3.3×	15	500
Nora Goldmann Germany	9	158 0.5×	116 0.4×	44 0.4×	31 1.0×	8 0.4×	17	215
Irene Kyomuhangi United Kingdom	5	353 1.1×	341 1.1×	27 0.3×	21 0.7×	5 0.3×	9	409
Rahul Mondal India	10	167 0.5×	146 0.5×	89 0.9×	41 1.4×	13 0.7×	14	270
Te Thammavong Thailand	8	261 0.8×	241 0.8×	27 0.3×	8 0.3×	14 0.8×	9	329
B. Seignères France	8	337 1.0×	313 1.1×	143 1.4×	38 1.3×	9 0.5×	9	375
M. Damen Netherlands	5	167 0.5×	161 0.5×	55 0.5×	42 1.4×	7 0.4×	8	233
G. Zeng China	6	356 1.1×	343 1.2×	40 0.4×	13 0.4×	15 0.8×	6	371
C. Trépo France	8	555 1.7×	526 1.8×	161 1.5×	19 0.6×	16 0.9×	12	581
Yu. V. Ostankova Russia	8	143 0.4×	121 0.4×	85 0.8×	18 0.6×	14 0.8×	87	241

Countries citing papers authored by Gaëtan Billioud

Since Specialization

Citations

This map shows the geographic impact of Gaëtan Billioud's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gaëtan Billioud with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gaëtan Billioud more than expected).

Fields of papers citing papers by Gaëtan Billioud

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gaëtan Billioud. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gaëtan Billioud. The network helps show where Gaëtan Billioud may publish in the future.

Co-authorship network of co-authors of Gaëtan Billioud

This figure shows the co-authorship network connecting the top 25 collaborators of Gaëtan Billioud. A scholar is included among the top collaborators of Gaëtan Billioud based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gaëtan Billioud. Gaëtan Billioud is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

Han, Kelong, Dickens Theodore, Eric E. Swayze, et al.. (2022). Preclinical and Phase 1 Assessment of Antisense Oligonucleotide Bepirovirsen in Hepatitis B Virus–Transgenic Mice and Healthy Human Volunteers: Support for Clinical Dose Selection and Evaluation of Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses. Clinical Pharmacology in Drug Development. 11(10). 1191–1202. 12 indexed citations

Billioud, Gaëtan, Christina Tryfonos, & Jan Richter. (2019). The Prevalence of Antibodies against Sandfly Fever Viruses and West Nile Virus in Cyprus. Journal of arthropod-borne diseases. 13(1). 116–125. 10 indexed citations

Billioud, Gaëtan, Robert L. Kruse, Melissa Carrillo, et al.. (2015). In vivo reduction of hepatitis B virus antigenemia and viremia by antisense oligonucleotides. Journal of Hepatology. 64(4). 781–789. 42 indexed citations

Billioud, Gaëtan, Manuel Carrillo, Denghui Gao, et al.. (2014). O119 IN VIVO INHIBITION OF HBV ANTIGENEMIA AND VIREMIA BY ANTISENSE OLIGONUCLEOTIDES. Journal of Hepatology. 60(1). S50–S50. 1 indexed citations

Billioud, Gaëtan, Christian Pichoud, Romain Parent, & Fabien Zoulim. (2012). Decreased infectivity of nucleoside analogs-resistant hepatitis B virus mutants. Journal of Hepatology. 56(6). 1269–1275. 11 indexed citations

Billioud, Gaëtan, Christian Pichoud, Gerhard Puerstinger, Johan Neyts, & Fabien Zoulim. (2011). The main Hepatitis B virus (HBV) mutants resistant to nucleoside analogs are susceptible in vitro to non-nucleoside inhibitors of HBV replication. Antiviral Research. 92(2). 271–276. 64 indexed citations

Villet, Stéphanie, Gaëtan Billioud, Christian Pichoud, et al.. (2008). In Vitro Characterization of Viral Fitness of Therapy-Resistant Hepatitis B Variants. Gastroenterology. 136(1). 168–176.e2. 62 indexed citations

Villet, Stéphanie, Christian Pichoud, Gaëtan Billioud, et al.. (2008). Impact of hepatitis B virus rtA181V/T mutants on hepatitis B treatment failure. Journal of Hepatology. 48(5). 747–755. 154 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact